| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 03, 2013 | SVP, GM - International | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 705 | $12.04 | 16,508 | |
| Aug 03, 2013 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 419 | $12.04 | 24,674 | |
| Aug 03, 2013 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 891 | $12.04 | 23,783 | |
| Aug 03, 2013 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,048 | $12.04 | 22,735 | |
| Jul 22, 2013 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,700 | $12.00 | 10,950 | |
| May 21, 2013 | CTO and COO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 948 | $10.96 | 11,963 | |
| May 09, 2013 | VP - Global Franchise | Form 4 | Open market or private sale of non-derivative or derivative security | 1,495 | $10.38 | 23,221 | |
| Mar 25, 2013 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,508 | $6.52 | 27,741 | |
| Mar 25, 2013 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,508 | -- | -- | |
| Mar 13, 2013 | Director | Form 4 | Other acquisition or disposition | -- | -- | 4,000 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.